Connected compound evidence
Tirzepatide (20mg)
Metabolic Research
Loading the shop...

In Stock
10mg · Lyophilised powder
Eloralintide 10mg lyophilised research vial, also identified as LY3841136. Read the amylin receptor evidence and current offer; no matching APS report is published.
For laboratory research only.
Early Black Friday: 20% off. Automatically applied.
Quantity
1 vial
Or choose express delivery for $15.99.
Estimate for these items only, before discount codes or payment fees. Final total in checkout.
No account needed · PayID / bank transfer
Analytical documentation
No published analytical report is linked to this format. Ask about documentation
Labelled quantity
10mg
Category
Metabolic Research
Order within the current dispatch window
Melbourne cut-off time updates live every second.
Time Remaining
22:10:56
Dispatch follows payment confirmation. Delivery options and cutoff terms
This listing identifies one vial of lyophilised Eloralintide labelled 10mg. LY3841136 is the research code used for Eloralintide in the cited literature. It is an amylin analogue with a selective receptor profile characterised in experimental assays. The Eloralintide guide separates those assays, animal experiments and human study records.
Cagrilintide is a different amylin analogue, not another name for Eloralintide. Tirzepatide has a different receptor target profile. Studies involving more than one compound require their own interpretation; a single-compound Eloralintide listing does not inherit the results or formulation of a combination. The research code and full compound name should remain attached to each comparison.
The label identifies nominal quantity in one research vial. It does not specify solution concentration or establish the receptor selectivity measured in a published assay. Compare the current offer using exact identity, labelled quantity, number of vials and the specification required by the laboratory method. Study enrolment and clinical formulation details belong in the evidence guide, not in a guarantee about this material.
No matching APS Eloralintide 10mg report is currently published. Review the analytical document library and ask for available identity, content and lot documentation. A primary paper characterising LY3841136 does not certify an independently supplied vial. For laboratory research only; not for human or veterinary use.
Stable research navigation
These links are based on catalogue family, evidence records, research topics and bundle composition. They do not imply therapeutic similarity.
Connected compound evidence
Metabolic Research
Connected compound evidence
Metabolic Research
Connected compound evidence
Metabolic Research
Connected compound evidence
Metabolic Research
Connected compound evidence
Research library
These resources separate compound identity, batch-quality questions and study evidence. A linked study does not establish that this catalogue material is equivalent to a medicine or investigational product.
Metabolic Research
Shared research topic
GH-Signalling Research